Andrew J. Fromkin - Apr 12, 2023 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role
Director
Signature
/s/ Eva Renee Barnett, attorney-in-fact for Andrew J. Fromkin
Stock symbol
IMVT
Transactions as of
Apr 12, 2023
Transactions value $
$0
Form type
4
Date filed
4/14/2023, 04:33 PM
Previous filing
Aug 19, 2022
Next filing
Dec 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMVT Common Stock Award $0 +12.5K +14.15% $0.00 101K Apr 12, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMVT Stock Option (right to buy) Award $0 +16.3K $0.00 16.3K Apr 12, 2023 Common Stock 16.3K $14.70 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares underlying restricted stock units awards ("RSUs").
F2 The RSUs vest in their entirety one year after the date of grant on April 12, 2024, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
F3 The shares underlying the options vest one year after the date of grant on April 12, 2024, subject to the Reporting Person's continuous service to the Issuer as of such date.